- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Sarnoff To Identify and Pursue Applications, Markets, and Licensees Under Five-Year Agreement
Sarnoff Corporation of Princeton, New Jersey, today announced a five-year strategic agreement with ExxonMobil Research and Engineering Company (EMRE) of Fairfax, Virginia, under which commercialization opportunities for EMRE's groundbreaking portfolio of mesoporous materials will be identified in markets outside of the petrochemical industry.
The materials, which include novel high surface area silicas, are among the first nanomaterials ever created and have been commercialized by ExxonMobil for its own use. Under the agreement Sarnoff will work with EMRE to position these materials in other markets, such as electronics and optics, where their unique properties offer significant advantages over current materials.
Sarnoff is also pursuing select third party participation in developing electronic systems and devices based on these nanomaterials. Opportunities in other applications will also be considered.
According to John Riganati, vice president of technology strategy for Sarnoff, both technical and business factors played a role in determining the initial areas of development.
"Sarnoff and ExxonMobil considered eight possible startup projects and chose three for initial exploration," said Riganati. "The selection was based on both the technical advantages of the materials and their business potential in each area."
EMRE's mesoporous materials include various types of molecular structures that can be tailored to the needs of a specific application. Sarnoff (www.sarnoff.com), formerly RCA Labs, is an international innovation services and product development company focusing on advanced technologies and applications in video, microelectronics, imagers, and related fields.
EMRE is the downstream research and engineering arm of ExxonMobil Corporation, a leading global oil, natural gas, and petrochemicals company whose subsidiaries have operations in approximately 200 countries and territories. More information regarding ExxonMobil and technologies it licenses can be found here.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Chemical cages: New technique advances synthetic biology February 10th, 2016
Superconductivity: Footballs with no resistance - Indications of light-induced lossless electricity transmission in fullerenes contribute to the search for superconducting materials for practical applications February 9th, 2016
Making sense of metallic glass February 9th, 2016
A fast solidification process makes material crackle February 8th, 2016
Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016
Cima NanoTech Debuts Large Interactive Touch Screens with European Customers at ISE 2016: For the first time in Europe, Cima NanoTech’s wide range of high performance, projected capacitive touch modules are showcased February 11th, 2016
Composite Pipe Long Term Testing Facility February 10th, 2016
Scientists take nanoparticle snapshots February 10th, 2016
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016